For: | Yang B, Zhao XH, Ma GB. Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases 2022; 10(23): 8205-8211 [PMID: 36159531 DOI: 10.12998/wjcc.v10.i23.8205] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i23/8205.htm |
Number | Citing Articles |
1 |
Yanyan Jiang, Jianhua Li, Juan Zhang, Sufang Chen. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1274025
|
2 |
Shuo Wang, Shengwu Chen, Yixuan Gao, Hongli Zhou. Bioinformatics led discovery of biomarkers related to immune infiltration in diabetes nephropathy. Medicine 2023; 102(35): e34992 doi: 10.1097/MD.0000000000034992
|
3 |
Youlv Lu, Ruolin Fang, Bolun Xu, Chunyun Feng, Zhentao Zhu, Meiting Yu, Yuhua Tong. A semantic segmentation method to analyze retinal vascular parameters of diabetic nephropathy. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1494659
|
4 |
Dongze Li, Li Zhang, Yanqiu He, Tingting Zhou, Xi Cheng, Wei Huang, Yong Xu. Novel histone post-translational modifications in diabetes and complications of diabetes: The underlying mechanisms and implications. Biomedicine & Pharmacotherapy 2022; 156: 113984 doi: 10.1016/j.biopha.2022.113984
|